National Colorectal Cancer Screening Program in Lithuania: Description of the 5-Year Performance on Population Level.

colorectal cancer colorectal cancer screening national cohort

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
06 Mar 2021
Historique:
received: 26 12 2020
revised: 02 02 2021
accepted: 22 02 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

We aimed to report the results of the implementation of the National Colorectal Cancer (CRC) Screening Program covering all the country. The National Health Insurance Fund (NHIF) reimburses the institutions for performing each service; each procedure within the program has its own administrative code. Information about services provided within the program was retrieved from the database of NHIF starting from the 1 January 2014 to the 31 December 2018. Exact date and type of all provided services, test results, date and results of biopsy and histopathological examination were extracted together with the vital status at the end of follow-up, date of death and date of emigration when applicable for all men and women born between 1935 and 1968. Results were compared with the guidelines of the European Union for quality assurance in CRC screening and diagnosis. The screening uptake was 49.5% (754,061 patients) during study period. Participation rate varied from 16% to 18.1% per year and was higher among women than among men. Proportion of test-positive and test-negative results was similar during all the study period-8.7% and 91.3% annually. Between 9.2% and 13.5% of test-positive patients received a biopsy of which 52.3-61.8% were positive for colorectal adenoma and 4.6-7.3% for colorectal carcinoma. CRC detection rate among test-positive individuals varied between 0.93% and 1.28%. The colorectal cancer screening program in Lithuania coverage must be improved. A screening database is needed to systematically evaluate the impact and performance of the national CRC screening program and quality assurance within the program.

Identifiants

pubmed: 33800772
pii: cancers13051129
doi: 10.3390/cancers13051129
pmc: PMC7961359
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Gut Liver. 2018 Mar 15;12(2):183-189
pubmed: 29212310
Cancers (Basel). 2020 May 29;12(6):
pubmed: 32486077
Cancer Epidemiol. 2015 Jun;39(3):388-93
pubmed: 25910865
World J Gastroenterol. 2017 May 28;23(20):3632-3642
pubmed: 28611516
Gastroenterology. 2017 Apr;152(5):1217-1237.e3
pubmed: 27769517
Endoscopy. 2013;45(1):27-34
pubmed: 23254404
West J Med. 1999 Nov-Dec;171(5-6):302-5
pubmed: 10639865
Eur J Cancer Prev. 2015 Mar;24(2):76-80
pubmed: 25370682
Public Health. 2021 Jan;190:67-74
pubmed: 33360029
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Med Screen. 2017 Sep;24(3):127-145
pubmed: 27754937
N Engl J Med. 2010 May 13;362(19):1795-803
pubmed: 20463339
Oncol Lett. 2015 Jul;10(1):433-438
pubmed: 26171046
J Gen Intern Med. 2021 Jan 28;:
pubmed: 33511567
Dig Liver Dis. 2017 Mar;49(3):308-311
pubmed: 27810401
Am J Gastroenterol. 2014 Aug;109(8):1257-64
pubmed: 24980879
Can Fam Physician. 2013 Dec;59(12):e541-9
pubmed: 24336559
Lancet. 2016 Feb 20;387(10020):751-9
pubmed: 26680217
J Gen Intern Med. 2021 Jan 20;:
pubmed: 33474640
J Paediatr Child Health. 2008 Jul-Aug;44(7-8):419-23
pubmed: 18564080
Prev Med. 2015 Apr;73:106-11
pubmed: 25602908
Ann Intern Med. 2016 Apr 5;164(7):456-63
pubmed: 26811150
Prev Med Rep. 2021 Jan 04;21:101308
pubmed: 33505841
Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1415-21
pubmed: 25244415
Am J Gastroenterol. 2002 Jun;97(6):1296-308
pubmed: 12094842
N Engl J Med. 1988 Sep 1;319(9):525-32
pubmed: 2841597
Cancer Epidemiol. 2015 Dec;39 Suppl 1:S139-52
pubmed: 26596722
J Clin Gastroenterol. 2017 Jul;51(6):e52-e59
pubmed: 27552327
Zhonghua Yi Xue Za Zhi. 2010 Oct 19;90(38):2679-83
pubmed: 21162896
Eur J Cancer Prev. 2018 May;27(3):227-236
pubmed: 28665812
Endoscopy. 2012 Sep;44 Suppl 3:SE49-64
pubmed: 23012122
Pharm World Sci. 2007 Dec;29(6):688-94
pubmed: 17479353
Acta Oncol. 2021 Mar;60(3):323-332
pubmed: 33427545
N Engl J Med. 1993 Dec 30;329(27):1977-81
pubmed: 8247072
N Engl J Med. 2014 Apr 3;370(14):1298-306
pubmed: 24693890
Endoscopy. 2013;45(1):51-9
pubmed: 23212726
Gut. 2013 Mar;62(3):409-15
pubmed: 22387523
Am J Health Promot. 2021 Mar;35(3):421-429
pubmed: 33504161

Auteurs

Audrius Dulskas (A)

Laboratory of Clinical Oncology, National Cancer Institute, 1 Santariskiu Str., LT-08406 Vilnius, Lithuania.
Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.

Tomas Poskus (T)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.

Inga Kildusiene (I)

Laboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.

Ausvydas Patasius (A)

Laboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.
Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.

Rokas Stulpinas (R)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.
National Centre of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, 5 P. Baublio Str., LT-08406 Vilnius, Lithuania.

Arvydas Laurinavičius (A)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.
National Centre of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, 5 P. Baublio Str., LT-08406 Vilnius, Lithuania.

Laura Mašalaitė (L)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.

Gabrielė Milaknytė (G)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.

Ieva Stundienė (I)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.

Lina Venceviciene (L)

Clinic of Internal Medicine, Family Medicine and Oncology, Faculty of Medicine, Vilnius University, LT-08410 Vilnius, Lithuania.
Centre of Family Medicine, Vilnius University Hospital Santaros Klinikos, LT-08410 Vilnius, Lithuania.

Kestutis Strupas (K)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.

Narimantas E Samalavicius (NE)

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.
Department of Surgery, Klaipeda University Hospital, 41 Liepojos Str., 92288 Klaipeda, Lithuania.
Health Research and Innovation Science Center, Faculty of Health Sciences, Klaipeda University, 84 Herkaus Manto Str., LT-92288 Klaipeda, Lithuania.

Giedre Smailyte (G)

Laboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.
Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.

Classifications MeSH